Chang-il Hwang
Affiliations: | 2012-2018 | Microbiology and Molecular Genetics | University of California, Davis, Davis, CA |
Google:
"Chang-il Hwang"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Usman OH, Zhang L, Xie G, et al. (2022) Genomic heterogeneity in pancreatic cancer organoids and its stability with culture. Npj Genomic Medicine. 7: 71 |
| Casolino R, Corbo V, Beer P, et al. (2022) Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care. Cancers. 14 |
| Zhang D, Lindstrom A, Kim EJ, et al. (2022) SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment. Frontiers in Oncology. 12: 890154 |
| Wang SS, Xu J, Ji KY, et al. (2021) Epigenetic Alterations in Pancreatic Cancer Metastasis. Biomolecules. 11 |
| Kim HR, Yim J, Yoo HB, et al. (2021) EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. Nar Cancer. 3: zcab023 |
| Nielsen SR, Strøbech JE, Horton ER, et al. (2021) Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Nature Communications. 12: 3414 |
| Miyabayashi K, Baker LA, Deschenes A, et al. (2020) Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes. Cancer Discovery |
| Oni TE, Biffi G, Baker LA, et al. (2020) SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. The Journal of Experimental Medicine. 217 |
| Ponz-Sarvise M, Corbo V, Tiriac H, et al. (2019) Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Hwang C, Roe J, Lee EJ, et al. (2019) Abstract B25: Engrailed-1 promotes pancreatic cancer progression via antagonizing COMPASS activity Cancer Research. 79 |